Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
French and Malaysian authorities are investigating Grok for generating sexualized deepfakes - 2The Most Enrapturing Authentic Milestones to Visit
- 3This cafe takes orders in sign language. It's cherished by the Deaf community
- 4Baby takes 1st steps after receiving groundbreaking gene-edited therapy
- 5Carrying on with a Sans plastic Way of life: Individual Examinations in Maintainability
- 'Hero' who wrestled gun from Bondi shooter named as Ahmed al Ahmed
- NASA’s Artemis II launch leaves Americans in awe: ‘We’re going to the frickin’ moon!’
- Best Quest for new employment Site for You to Track down Amazing open doors
- Germany's Deutsche Welle broadcaster declared 'undesirable' in Russia
- Full Supreme Court to hear challenge to Judicial Selection Committee law
- Flourishing in a Cutthroat Work Market: Vocation Methodologies
- Medtronic has 'significant firepower' for multiple acquisitions, executives say
- Israel strikes Iranian nuclear development facilities, Tehran vows retaliation
- Picking the Right Doctor prescribed Medication Inclusion in Senior Protection.
